Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market to Register Immense Growth by 2032 – Asserts DelveInsight | Key Companies – UCB, Galapagos, Novartis, Sun Pharma, and Others

Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market to Register Immense Growth by 2032 – Asserts DelveInsight | Key Companies – UCB, Galapagos, Novartis, Sun Pharma, and Others

Delveinsight Business Research LLP As per DelveInsight, the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Therapeutics Market dynamics are expected to transform in the coming years owing to the launch of emerging therapies,

Read More

Follicular Lymphoma Therapeutics Pipeline Assessment | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, Treatment Outlook, and Key Companies Involved

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, nearly 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Follicular Lymphoma therapeutics landscape based on

Read More

Natural Killer (NK)-Cell Lymphoma Pipeline Assessment | FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, Growth Prospects, and Key Companies Involved

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, nearly 100+ key pharma and biotech companies are working on 140+ pipeline drugs in the Natural Killer (NK)-Cell Lymphoma therapeutics landscape

Read More

Acute Lymphocytic Leukemia Therapeutic Pipeline Analysis | Insights into the Latest FDA, EMA, and PMDA Approvals, Clinical Trials, Emerging Therapies, Treatment Algorithm, and Key Companies Involved

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, nearly 250+ key pharma and biotech companies are working on 250+ pipeline drugs in the Acute Lymphocytic Leukemia therapeutics landscape based

Read More

Non-Muscle Invasive Bladder Cancer Pipeline Analysis | Insights into the Marketed and Emerging Therapies, Latest Regulatory Approvals, Clinical Trials, Treatment Outlook, Key Companies by DelveInsight

Non-Muscle Invasive Bladder Cancer Pipeline With over 30+ players proactively involved in developing novel therapies for Non-Muscle Invasive Bladder Cancer (NMIBC) and over 30+ therapies expected to get launched, Non-Muscle

Read More

Anti-CD19 Antibody Pipeline Report | Companies- Sanofi, Incyte Corporation, Amgen, Viela Bio, TG Therapeutics, Merck kGaA, Generium Pharmaceutical, and others

Anti-CD19 Antibody Pipeline Approximately 15+ key companies are developing Anti-CD19 Antibody. The companies with their Anti-CD19 Antibody-drug candidates in the most advanced stage include Viela Bio, ADC Therapeutics, Amgen, Morphosys and Xencor. DelveInsight’s

Read More

Fashion Influencer Marketing Market Development, Trends, Demand and Forecast Till 2022-2027

Looking forward, IMARC Group expects the global fashion influencer marketing market to continue its robust growth during the forecast period (2022-2027). The IMARC Group provides extensive analysis of the fashion

Read More

Ultrasound Market Growing at a CAGR of 6.3% – Research Provides Detailed Analysis of Trends, Growth and Forecast

GE Healthcare (a key business division of General Electric Company) is among the top players engaged in the development and manufacturing of diagnostic ultrasound systems. The company focuses on maintaining

Read More

Web Hosting Services Market Trends, Scope, Demand, Opportunity and Forecast 2022-2027

Looking forward, IMARC Group expects the global web hosting services market to continue its robust growth during the forecast period (2022-2027). The IMARC Group provides extensive analysis of the web

Read More

Customer Self-Service Software Market Share, Size, Growth, Demand and Forecast Till 2022-2027

Looking forward, IMARC Group expects the global customer self-service software market to continue its robust growth during the forecast period (2022-2027). The IMARC Group provides extensive analysis of the customer

Read More